ACUS 0.00 Acusphere, Inc.
| Range: | 1.0E-6-1.0E-5 | Vol Avg: | 0 | Last Div: | 0 | Changes: | -0.03 |
| Beta: | -0.14 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed Oct 08 2003 | Empoloyees: | |||
| CUSIP: | 00511R854 | CIK: | ISIN: | US00511R8549 | Country: | US | |
| CEO: | Dr. William I. Ramage D.Phil | Website: | https://www.acusphere.com | ||||
Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow